I-Mab Announces $65 Million Underwritten Offering of American Depositary Shares
I-Mab, a biotech company making waves in the stock market, has launched a $65 million offering. This move, announced on August 1, 2025, involves selling American Depositary Shares to fund its clinical programs. Investors now have a chance to see how this affects I-Mab and the stock market as a whole.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
